金城医药

- 300233

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016 
金城医药(300233) 利润表
单位:万元
报表日期2025-09-302025-06-302025-03-312024-12-312024-09-30
一、营业总收入193,202.56136,024.0772,191.92337,338.74251,531.84
营业收入193,202.56136,024.0772,191.92337,338.74251,531.84
二、营业总成本189,136.21130,998.2468,209.12310,316.41233,320.64
营业成本123,210.2186,877.1847,520.54201,959.94150,587.77
营业税金及附加2,714.641,797.60925.063,927.052,927.26
销售费用24,061.2516,034.317,479.4949,638.7138,954.79
管理费用27,698.6618,793.599,017.2137,846.2128,439.33
财务费用268.37104.96-15.58-89.88155.80
研发费用11,183.087,390.613,282.4017,034.3712,255.69
资产减值损失----------
公允价值变动收益-10.87-14.39-0.078.65-30.51
投资收益96.1496.7481.79-166.51-152.43
其中:对联营企业和合营企业的投资收益-16.1820.1141.42-40.26-41.12
汇兑收益----------
三、营业利润5,288.516,211.735,009.2826,713.8219,526.64
加:营业外收入24.8013.933.88384.65217.54
减:营业外支出255.52247.1633.16253.6650.02
其中:非流动资产处置损失----------
四、利润总额5,057.785,978.504,980.0026,844.8019,694.16
减:所得税费用1,697.981,481.891,350.116,071.273,484.08
五、净利润3,359.814,496.613,629.8920,773.5316,210.08
归属于母公司所有者的净利润3,157.714,338.323,505.4819,678.0815,105.38
少数股东损益202.10158.29124.411,095.461,104.70
六、每股收益
基本每股收益(元/股)0.08000.11000.09000.52000.4000
稀释每股收益(元/股)0.08000.11000.09000.52000.4000
七、其他综合收益-3.36-210.00--2,326.86--
八、综合收益总额3,356.454,286.613,629.8923,100.3916,210.08
归属于母公司所有者的综合收益总额3,154.354,128.323,505.4822,004.9315,105.38
归属于少数股东的综合收益总额202.10158.29124.411,095.461,104.70
下载全部历史数据到excel中 返回页顶